Try a single issue or save on a subscription Issues delivered straight to your door or device ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...
The medication is not a replacement for CPAP ... sleep apnea, and cardiovascular risk factors, these drugs often remain outside the reach of people who need them the most because of their cost ...
Medicare has announced the expansion of coverage for Eli Lilly’s Zepbound, a breakthrough drug in the treatment of autoimmune ...
For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...
Sleep apnea has historically been treated with therapies such as the use of a continuous positive airway pressure (CPAP) machine ... medications because of their cost.
The trials assessed participants using the apnea-hypopnea index (AHI), which measures the frequency of breathing interruptions during sleep. In one trial where participants did not use CPAP ...